Syncona Ltd, a leading life sciences company headquartered in Great Britain, focuses on building and financing innovative biotechnology businesses. Founded in 2016, Syncona has rapidly established itself in the healthcare sector, particularly in the development of advanced therapies and regenerative medicine. With a strong operational presence in the UK and the US, Syncona is dedicated to creating and supporting companies that address significant unmet medical needs. Its unique approach combines deep scientific expertise with strategic investment, enabling the development of cutting-edge products and services. Notable achievements include a robust portfolio of companies that are pioneering breakthroughs in gene therapy and cell therapy. Syncona's commitment to innovation positions it as a key player in the life sciences industry, driving advancements that have the potential to transform patient care.
How does Syncona's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Services Auxiliary to Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Syncona's score of 47 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Syncona reported total carbon emissions of approximately 492,300 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 491,400 kg CO2e. Within this, business travel was the largest contributor at approximately 480,500 kg CO2e. Scope 1 emissions were about 930 kg CO2e, while Scope 2 emissions (location-based) totalled approximately 197,000 kg CO2e. In 2023, Syncona's total emissions were approximately 192,600 kg CO2e, with Scope 3 emissions again dominating at about 191,900 kg CO2e. Scope 1 emissions were around 740 kg CO2e, and Scope 2 emissions (location-based) reached approximately 250,000 kg CO2e. For 2022, emissions data indicated a total of about 65,000 kg CO2e, with Scope 3 emissions contributing approximately 52,800 kg CO2e. Scope 1 emissions were around 400 kg CO2e, and Scope 2 emissions were about 11,800 kg CO2e. Syncona has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 greenhouse gas emissions by 80% by 2030, using 2020 as the base year. This target has been validated by the Science Based Targets initiative (SBTi), reflecting the company's commitment to significant decarbonisation efforts in the near term.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 700 | 000 | 000 |
| Scope 2 | - | 000,000 | 000,000 |
| Scope 3 | 53,200 | 000,000 | 000,000 |
Syncona's Scope 3 emissions, which increased by 156% last year and increased by approximately 824% since 2022, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 71% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 3028% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Syncona has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
